Thursday - April 25, 2024

Category Archives: Financial Market

Pancreatic Neuroendocrine Tumors (PNETS) Market Gearing Up for Outstanding Expansion During the Forecast Period (2023-32) | Novartis, Ipsen Pharma, Pfizer, Hutchison Medipharma, TaiRx

Delveinsight Business Research LLP As per DelveInsight, the Pancreatic Neuroendocrine Tumors (PNETS) Market is anticipated to evolve immensely in the coming years owing to the increasing prevalent population of PNETs patients in the 7MM, along with the expected entry of … Continue reading →

Ocular Hypertension Pipeline Analysis (2023) Covering Clinical Trials, Emerging Therapies, FDA, EMA, and PMDA Approvals, Competitive Landscape | Nicox, Qlaris Bio, TheratOcula, Ocular Therapeutix

Delveinsight Business Research LLP As per DelveInsight’s assessment, globally, about 70+ key pharma and biotech companies are working on 75+ pipeline drugs in the Ocular Hypertension therapeutics landscape based on different Routes of Administration (ROA), Mechanism of Action (MOA), and … Continue reading →

Dilated Cardiomyopathy Market Forecasts by DelveInsight Signal Groundbreaking Growth by 2032 | Renovacor, Pfizer, Longeveron, MyoKardia, Vericel, Tenaya Therapeutics, Cardior Pharmaceuticals

Delveinsight Business Research LLP The Dilated Cardiomyopathy Market size in the 7MM was USD 303.7 million in 2022, and it is expected to grow by 2032. As per DelveInsight, the Dilated Cardiomyopathy Market is anticipated to evolve immensely in the … Continue reading →

Hypoparathyroidism Market on the Verge of Extraordinary Growth During the Forecast Period (2023-32) | ProLynx, Shire, Sigilon, Amolyt Pharma, Ascendis, Bridgebio, Calcilytix, Entera Bio

Delveinsight Business Research LLP The Hypoparathyroidism Market size in the 7MM was found to be USD 235 million in 2021, and it is anticipated to increase during the study period (2019–2032). The Hypoparathyroidism Market is set to register immense growth … Continue reading →

HR Positive/ HER2 Negative Breast Cancer Pipeline Analysis (2023) Covering Clinical Trials, Emerging Therapies, FDA, EMA, PMDA Approvals, Competitive Landscape | AstraZeneca, Daiichi Sankyo, CytomX

Delveinsight Business Research LLP As per DelveInsight’s assessment, globally, about 50+ key pharma and biotech companies are working on 53+ pipeline drugs in the HR Positive/ HER2 Negative Breast Cancer therapeutics landscape based on different Routes of Administration (ROA), Mechanism … Continue reading →

My Size Inc (MYSZ) Emerging AI-driven Measurement Solutions Company Receives Bullish Target From Wall Street Analyst

Source: https://www.precedenceresearch.com/artificial-intelligence-market My Size, Inc. (Nasdaq: MYSZ) has demonstrated remarkable growth and resilience in the second quarter of 2023. With substantial increases in revenue, gross profit, and a narrowing of losses, the company is on a path of sustained success. … Continue reading →

Internet gaming visionary leads little-known company Esports Entertainment Group Inc (GMBL) into potential $24 billion esports market

Pictured above with Las Vegas Mayor Carolyn Goodman The rise of short-form competitive content, also known as short-cycle wage-rable esports content, is revolutionizing the esports industry and presenting a game-changing opportunity for Esports Entertainment Group, Inc. (Nasdaq: GMBL). Esports has … Continue reading →